Neurotechnology in 2017: Caregiver Apps You May Have Missed

These medical apps provided technology for caregivers to track symptoms, make appointments with doctors, monitor medications, and more.

Related Videos
Related Content

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Special Episode: Lecanemab Approved for Alzheimer Disease

January 9th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 79: A New Monoclonal for Alzheimer Disease

December 16th 2022

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Special Episode: Lecanemab Approved for Alzheimer Disease

January 9th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 79: A New Monoclonal for Alzheimer Disease

December 16th 2022

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Special Episode: Lecanemab Approved for Alzheimer Disease

January 9th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 79: A New Monoclonal for Alzheimer Disease

December 16th 2022

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023
© 2023 MJH Life Sciences

All rights reserved.